AHA/ACC Release Updated Guidelines for Cholesterol Management
Updated cholesterol guidelines offer more personalized cardiovascular disease risk assessment.
Updated cholesterol guidelines offer more personalized cardiovascular disease risk assessment.
Findings may have implications for future cholesterol treatment paradigms.
High total HDL cholesterol in postmenopausal women may mask heart disease risk.
Investigators examined renal outcomes when controlling cardiovascular risk factors, such as blood pressure, LDL-C, and HbA1c.
Cognitive decline risk is lowered in individuals aged 85 and older with high cholesterol.
PCSK9 inhibition produces incremental benefits on coronary disease progression in patients treated with statins.
Researchers observed significant improvement in LDL cholesterol in those at risk for diabetes.
Statin-based therapy had a smaller effect in reducing major vascular events in patients with advanced chronic kidney disease.
Researchers found that dietary changes, other medications, and surgery can also lower cardiovascular risk.
Current evidence is insufficient to weigh the balance of benefits and harms of screening.